These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37993376)

  • 21. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
    Targher G; Rossini M; Lonardo A
    Endocrine; 2016 Feb; 51(2):211-21. PubMed ID: 26024975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
    Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
    Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Pan B; Cai J; Zhao P; Liu J; Fu S; Jing G; Niu Q; Li Q
    Osteoporos Int; 2022 Nov; 33(11):2275-2286. PubMed ID: 35764892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease and the risk of urolithiasis: A systematic review and meta-analysis.
    Qin S; Wang S; Wang X; Wang J
    Medicine (Baltimore); 2018 Aug; 97(35):e12092. PubMed ID: 30170429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.
    Jaroenlapnopparat A; Rittiphairoj T; Chaisidhivej N; Walker B; Charoenngam N
    Diabetes Metab Syndr; 2023 Aug; 17(8):102827. PubMed ID: 37451113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Pan L; Sui J; Xu Y; Zhao Q
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
    Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
    Bellinato F; Gisondi P; Mantovani A; Girolomoni G; Targher G
    J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study.
    Adrian T; Sørensen IMH; Knop FK; Bro S; Ballegaard ELF; Nordestgaard BG; Fuchs A; Kofoed KF; Kühl JT; Sigvardsen PE; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2022 Sep; 37(10):1927-1934. PubMed ID: 34505899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
    Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression.
    Orci LA; Sanduzzi-Zamparelli M; Caballol B; Sapena V; Colucci N; Torres F; Bruix J; Reig M; Toso C
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):283-292.e10. PubMed ID: 33965578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis.
    Xue J; Xin H; Ren N; Zhou C; Yang J; Song L; Qin S
    Eur J Clin Invest; 2019 Sep; 49(9):e13158. PubMed ID: 31338830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies.
    Gu Y; Zhang W; Hu Y; Chen Y; Shi J
    J Affect Disord; 2022 Mar; 301():8-13. PubMed ID: 34986375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review.
    Kobayashi T; Iwaki M; Nogami A; Honda Y; Ogawa Y; Imajo K; Saito S; Nakajima A; Yoneda M
    Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Heydari K; Yousefi M; Alizadeh-Navaei R; Lotfi P; Sheydaee F; Raei M; Vahdatinia A; Hessami A; Rafati S; Moosazadeh M; Ghasemian R; Salehi F; Massoudi H; Ghaffari-Saravi F; Rismantab S
    Turk J Gastroenterol; 2022 Mar; 33(3):171-181. PubMed ID: 35410853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.